Skip to content
Archive

KOLINPHARMA® expands its product portfolio with IVUXUR® TABLETS

KOLINPHARMA® S.p.A. presents its new product IVUXUR® tablets, which joins the 9 products already in its portfolio that are patented or patent pending.

The new product, formulated in the innovative form of a three-layer tablet, is a food supplement containing substances that support urinary tract well-being. This new product is the result of a technological and development path successfully carried out by the in-house Research and Development department, and it will sit alongside IVUXUR® sachets to reach a new group of patients and broaden the commercial offer in its market.

With the launch of this new product, KOLINPHARMA® gives concrete confirmation of its commitment to supporting the well-being of patient-consumers, always alongside the specialist doctor with technologically advanced formulations.

Rita Paola Petrelli, President of Kolinpharma, comments: “What sets Kolinpharma® apart is its constant pursuit of innovation and development in the field of nutraceuticals. Since our foundation we have put R&D investment at the centre, believing in the strength and commitment of our researchers and working with the academic world […]. Our goal is to keep innovating as we continue to climb the ranking of nutraceutical companies”.

Read the press release

More news

  1. KOLINPHARMA: NUOVA CONCESSIONE DI BREVETTO PER MILESAX®
  2. Kolinpharma®: primo brevetto per Miledix®, salgono a 5 i brevetti in Italia
  3. Una forte espansione sul Mercato Europeo
Archive